Manuel Aivado
CIK 1709603 · See Remarks · last filed 2025-07-23
Manuel Aivado is a corporate insider who has filed 11 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for RNTX, was dated Jul 23, 2025. Across all open-market trades the lifetime net is +$5.6K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
11
$5.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RNTX | Director | — | $0.96 | — | $0 | 1 | 2025-07-23 |
| Rein Therapeutics, Inc. (ALRN) Delisted | See Remarks | 1,000 | $2.11 | $2.1K | $5.6K | 10 | 2024-12-06 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-23 | RNTX | Grant (A) | — | $0 | EDGAR |
| 2024-12-06 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-08-22 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-30 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-24 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-04 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-17 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-09-07 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-08 | Rein Therapeutics, Inc. (ALRN) Delisted | Buy (P) | +1,000 | $5.6K | EDGAR |